Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study-Reference-Cited by-同舟云学术

Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study

Published:2020-07 Issue:7 Volume:5 Page:649-657
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Feld Jordan J,Cypel Marcelo,Kumar Deepali,Dahari Harel,Pinto Ribeiro Rafaela Vanin,Marks Nikki,Kamkar Nellie,Bahinskaya Ilona,Onofrio Fernanda Q,Zahoor Mohamed A,Cerrochi Orlando,Tinckam Kathryn,Kim S Joseph,Schiff Jeffrey,Reichman Trevor W,McDonald Michael,Alba Carolina,Waddell Thomas K,Sapisochin Gonzalo,Selzner Markus,Keshavjee Shaf,Janssen Harry L A,Hansen Bettina E,Singer Lianne G,Humar Atul

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference33 articles.

1. The drug overdose epidemic and deceased-donor transplantation in the United States: a national registry study;Durand;Ann Intern Med,2018

2. Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection;Feld;N Engl J Med,2015

3. Glecaprevir–pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 infection;Zeuzem;N Engl J Med,2018

4. Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients: an open-label nonrandomized trial;Durand;Ann Intern Med,2018

5. Heart and lung transplants from HCV-infected donors to uninfected recipients;Woolley;N Engl J Med,2019

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world experience in treatment of donor‐derived Hepatitis C virus in kidney transplant recipients with delayed initiation, shortened course glecaprevir/pibrentasvir versus standard of care;Transplant Infectious Disease;2024-09-03

2. Surveillance for donor‐derived infections in Australia;Transplant Infectious Disease;2024-06-10

3. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review;Microorganisms;2024-05-21

4. Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals;Expert Opinion on Pharmacotherapy;2024-05-02

5. Utilising organs from hepatitis C virus PCR‐positive donors in Western Australia;Internal Medicine Journal;2024-03-07